Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Chapman

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|November 1, 1993
Identification of children with and without cleft palate from tape-recorded samples of early vocalizations and speechD R Van Demark, M A Hardin-Jones, M M O'Gara, et al.
Molecular Pharmacology|November 1, 1994
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivoS Patel, A J Smith, K L Chapman, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
Journal of Medicinal Chemistry|August 1, 1997
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.
Human Genetics|August 19, 2016
Multipoint genome-wide linkage scan for nonword repetition in a multigenerational family further supports chromosome 13q as a locus for verbal trait disordersD T Truong, L D Shriberg, S D Smith, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptorS Patel, S Freedman, K L Chapman, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|November 1, 1993
Identification of children with and without cleft palate from tape-recorded samples of early vocalizations and speechD R Van Demark, M A Hardin-Jones, M M O'Gara, et al.
Molecular Pharmacology|November 1, 1994
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivoS Patel, A J Smith, K L Chapman, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
Journal of Medicinal Chemistry|August 1, 1997
5-(Piperidin-2-yl)- and 5-(homopiperidin-2-yl)-1,4-benzodiazepines: high-affinity, basic ligands for the cholecystokinin-B receptorJ L Castro, H B Broughton, M G Russell, et al.
Human Genetics|August 19, 2016
Multipoint genome-wide linkage scan for nonword repetition in a multigenerational family further supports chromosome 13q as a locus for verbal trait disordersD T Truong, L D Shriberg, S D Smith, et al.
Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptorS Patel, S Freedman, K L Chapman, et al.
Pageof 3